NRX Pharmaceuticals, Inc. (NRXP) Insider Trading

Name: NRX Pharmaceuticals, Inc. (NRXP) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Feb 18, 2026): Casper Joseph Michael (Chief Operating Officer): Grant/Award of 100,000 shares.

Get alerted when insiders trade NRXP

Email address

Loading company data...

Loading company details...